Pharmaceuticals Market Reports

Kalorama Information is your trusted source for market research on the pharmaceutical industry. Reports provide key trends, projections, and in-depth analysis for the markets you compete in. Our analysts work closely with pharmaceutical industry leaders to provide accurate market assessments while personally researching the market to offer keen insights into consumer and institutional trends.

<< back 1 2 3 4 5 6 7 8 9 10 next >>

Title	Published	Price
Cosmetic Surgery Market: Procedure Volumes and Fees for the Top Five Procedures, 2002-2006 Based on findings from Kalorama Information’s research study Facial Cosmetic Surgery and Rejuvenation Markets: Business, Technologies, and Competitive Intelligence (July 2004), this summary covers the top five surgeries and an “other” category. The top five procedures are: Breast augmentation/reduction Liposuction Rytidectomy (face lifts) Blepharoplasty (eyelid lift) Rhinoplasty (nose job)  |  more... Search inside this report	Oct 1, 2004	$395.00
New Anticoagulant Therapies: A Market Briefing There is a pressing need for new anticoagulant therapeutics in human medicine. To meet this need, developers are reformulating traditional cornerstone therapeutics such as heparin and looking to new classes such as DTIs to prevent stroke and myocardial infarction and treat deep vein thrombosis and a host of other emerging  |  more... Search inside this report	Oct 1, 2004	$895.00
Wellness Market Opportunities in the Aging American Population: Alternative Medicine Markets for Age-Related Health Issues With an aging population in the United States, the incidence of prevalence of age-related diseases and disorders is expected to mount rapidly over the next decade. Since senior citizens already consume a disproportionate amount of healthcare dollars, the economic picture will only go from bad to worse insofar as  |  more... Buy by the section | Search inside this report	Sep 1, 2004	$3,500.00
Ambulatory Infusion Pumps in Pain Management: A Market Briefing After years of neglect, concerns over pain, how it is assessed and managed on a patient-by-patient basis have captured the attention of health care professionals and the public. There are a variety of issues that have acted to draw this attention, including the high prevalence of pain, continuing evidence that  |  more... Search inside this report	Aug 1, 2004	$895.00
The U.S. Market for Over-the-Counter Gastrointestinal Products, 2nd Edition The market for OTC Gastrointestinal products has gone through several significant changes in the past 5 years, most of which have to do with the Rx-to-OTC switches of two types of gastroesophageal reflux disease (GERD) drugs: H2 receptor antagonists and proton pump inhibitors (PPIs). This report on the U.S. market  |  more... Buy by the section | Search inside this report	Aug 1, 2004	$2,995.00
Immunomodulators in Cancer Therapy: Emerging Products and Markets This Kalorama Information report focuses on current and emerging immunomodulators for cancer. The report covers both current and emerging cancer immunomodulators in detail. The report includes statistical information for cancers by type worldwide, with special emphasis on the U.S. market. Specifically, cancers where there are current  |  more... Buy by the section | Search inside this report	Aug 1, 2004	$3,500.00
Inhaled Insulin: A Market Briefing Alternative routes of administration for insulin has been one of the leading drivers of drug delivery industry. Although transdermal and transmucosal systems have shown promise and true oral delivery remains a goal, pulmonary delivery has emerged as the leading area of development. Several major players in the pharmaceutical industry have  |  more... Search inside this report	Jul 1, 2004	$895.00
Pharmaceutical Outsourcing Opportunities Post Launch: Contract Manufacturing, and Sales and Marketing After decades of sustained growth and profitability, the pharmaceutical industry has been positioned as one of the few recession proof industries based on its performance through multiple economical cycles. In recent years, there have been visible strains in the pharmaceutical business. With a downturn in fortunes, many pharmaceutical companies  |  more... Buy by the section | Search inside this report	Jul 1, 2004	$3,500.00
Facial Cosmetic Surgery and Rejuvenation Markets New technologies and alternatives to traditional cosmetic surgery have opened up a huge new market for anti-aging products. Cosmetic facial rejuvenation is no longer the purview of plastic surgeons, but represents a booming cash business for a large number of dermatologist and other practitioners. Botox, dermal fillers, resurfacing modalities, lasers,  |  more... Buy by the section | Search inside this report	Jul 1, 2004	$3,500.00
Early Stage Drug Discovery 2004: Combi-chem & High Throughput Screening Revisited Ten years ago, high throughput screening (HTS) was being touted as the answer to improving productivity in drug discovery. If screening thousands of compounds a week was good, screening hundreds of thousands would be even better. This led to the boom in Ultra HTS (UHTS), manufacturing-scale systems, and  |  more... Buy by the section | Search inside this report	Jun 1, 2004	$2,995.00
Monoclonal Antibodies in Cancer Therapy: Emerging Products and Markets In 2003, the market for monoclonal antibodies in the treatment of cancer is just short of $2.8 billion and growing at a phenomenal rate. The market is fueled by leading products such as Rituxan and Herceptin; however, other products continue to demand more attention each year. This study  |  more... Buy by the section | Search inside this report	Jun 1, 2004	$3,500.00
The Market for Generic Biologics: Issues, Trends, and Market Potential Biologics, or biopharmaceuticals, are synthetic or recombinant versions of natural biologic substances, including proteins such as enzymes or antibodies and nucleic acids such as DNA or RNA. Generic products are non-patented chemical and therapeutic equivalents of brand name drugs. However, biogenerics are not generic biologics, because there can technically be  |  more... Buy by the section | Search inside this report	Jun 1, 2004	$1,500.00
Medicare Reform and the Pharmaceutical Industry: Implications of the Medicare Prescription Drug Improvement and Modernization Act of 2003 The hard-fought battle over Medicare's prescription drug benefit is over, but the long-term effects of the new law are still unclear. Exactly who will benefit and by how much? Is it a victory for big pharma? Initial reactions are not always correct, and this examination into the true implications for  |  more... Search inside this report	Mar 1, 2004	$795.00
Growth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline Growth factors are gene products that play important roles in the regulation of cell division and tissue proliferation. Generally, the binding of a growth factor to its receptor initiates or blocks the ability of cells to divide and multiply. Blood and tissue growth factors have become exciting targets for compounds  |  more... Buy by the section | Search inside this report	Mar 1, 2004	$3,500.00
Cardiovascular Disease: The 45+ Market in the United States for Drugs and Medical Devices Cardiovascular disease includes chronic conditions such as hypertension, congestive heart failure and atherosclerosis, as well as such acute conditions as myocardial infarction and cardiac arrest. While cardiovascular disease may be diagnosed at any age, it is most prevalent in later years, particularly among sedentary individuals who are also overweight  |  more... Buy by the section | Search inside this report	Mar 1, 2004	$2,995.00
Markets in Geriatric Medicine: 45+ Market in the United States, Volumes I - III Markets in Geriatric Medicine is a collection of reports that address the technologies and markets associated with age-related disorders and diseases. As the American population ages, with the “Baby Boom” generation approaching the age of retirement and Medicare benefits, the incidence and prevalence of age-related disorders is expected to  |  more...	Mar 1, 2004	$7,200.00
The Emerging Cancer Vaccine Market Immunologic approaches to cancer therapy are not only increasing in reputation and number, but the market for these products is increasingly becoming a reality. Vaccines are in the forefront of this approach to cancer, and the handful of cancer vaccine products currently on the market for bladder, colon, and skin  |  more... Buy by the section | Search inside this report	Feb 1, 2004	$3,500.00
The Worldwide Market for Prescription Dermatological Drugs - 4th Edition This report provides the reader with a comprehensive analysis of the domestic and international markets involving pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatologic Drugs is the fourth time Kalorama Information has comprehensively studied the dermatology markets. For this latest  |  more... Buy by the section | Search inside this report	Feb 1, 2004	$3,500.00
The U.S. Market for OTC Diet Aids Diet Aids are among the most rapidly growing categories of over-the-counter (OTC) products. Between 1998 and 2003, growth was driven by two main factors: changes in laws and lawsuits relating to the industry, and changes in consumer attitudes toward weight loss. Because both of these factors are subject to rapid  |  more... Buy by the section | Search inside this report	Feb 1, 2004	$3,000.00
Type II Diabetes: The 45+ Market in the United States for Drugs and Diagnostics Type II diabetes is a metabolic disease the increases in incidence and prevalence with age. Type II diabetes (also known as "adult onset diabetes" and "non-insulin dependent diabetes") is a disease of glucose metabolism in which the individual becomes resistant to the glucose produced by the pancreas. As  |  more... Buy by the section | Search inside this report	Jan 1, 2004	$2,995.00
Outsourcing in Drug Development: The Contract Research Market from Preclinical to Phase III The cost of drug development has soared during the past ten years compelling pharmaceutical and biotechnology companies to look for new, smarter ways of conducting clinical research. Driven by mounting market pressures, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their  |  more... Buy by the section | Search inside this report	Jan 1, 2004	$3,500.00
Drug Delivery Technology and Applications: A summary of Kalorama's market research, 2001-2003 Over the past three years, Kalorama Information's analysts have studied drug delivery markets from several angles. In 2001 and 2002, we published a 5-volume series on drug delivery technology, each volume devoted to a route of administration: Volume I: Oral Drug Delivery Volume II: Injectable and Implantable Drug Delivery  |  more... Search inside this report	Nov 7, 2003	$746.00
The Market for Lead Optimization Tools and Services: Applying the new "-omics" to enhance drug discovery The process of creating a new drug is lengthy and complex. From discovery to development to market, there are numerous pitfalls. In this report, Kalorama focuses on one of the trickiest yet also most promising areas: the interface between discovery and development known as lead optimization. The pressure is  |  more... Buy by the section | Search inside this report	Nov 1, 2003	$1,875.00
Rheumatoid Arthritis: The 45+ Market in the United States for Drugs and Biologics Rheumatoid arthritis is a progressive disease of the joint structure that may be localized or systemic. It varies significantly in severity, producing symptoms that range from minor aches to severe disability and joint deformity. While rheumatoid arthritis can be diagnosed at any age, for childhood to the later  |  more... Buy by the section | Search inside this report	Nov 1, 2003	$2,246.00
Growth Factors: Indications, Products, and Markets Growth factors are gene products that play important roles in the regulation of cell division and tissue proliferation. Generally, the binding of a growth factor to its receptor initiates or, in some cases, blocks the ability of cells to divide and multiply. The nature and mode of action of these  |  more... Buy by the section | Search inside this report	Oct 1, 2003	$2,625.00
Title	Published	Price

<< back 1 2 3 4 5 6 7 8 9 10 next >>